With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India’s booming obesity drug market.
Wegovy vs Mounjaro: Eli Lilly to launch full-dose pen device in India as obesity drug race heats up
by Live mint | June 26, 2025 4:04 pm | Indian Stocks, Market, News